PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease Reportsbronchiectasis
MeSH D001987 - bronchiectasis
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D001982:Bronchial diseases
0 Companies
0 Drugs
Success rate
D001987: 
Bronchiectasis
$
Success rate
D007619:Kartagener syndrome
0 Companies
0 Drugs
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
Rising PharmaceuticalsAcetylcysteine Acetylcysteine  2015-03-24   
Zydus TherapeuticsAcetylcysteine Acetylcysteine  2018-07-20   
HospiraAcetylcysteine Acetylcysteine  1989-05-01   
Arbor PharmaceuticalsAcetylcysteine Cetylev 2032-05-08 2016-01-29   
Bristol Myers SquibbAcetylcysteine Mucomyst  1982-01-01   
AlvogenAcetylcysteine Acetylcysteine  2012-06-21   
Cumberland PharmaceuticalsAcetylcysteine Acetadote 2025-08-24 2004-01-23 $0.164 M Q4/23-Q3/24 
Roxane LaboratoriesAcetylcysteine Acetylcysteine  1992-04-30   
Eugia Pharma SpecialtiesAcetylcysteine Acetylcysteine  2016-02-29   
Fresenius KabiAcetylcysteine Acetylcysteine  2012-11-07   
1
2
>
Clinical Trials
Historical Success Rate
Phase 1
43%
3/7
Phase 2
57%
8/14
Phase 3
33%
5/15
Approved: 1Overall Success rate: 8%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Arbor Pharmaceuticals
1
2
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use